292 results about "Low blood pressures" patented technology

A system for determining a biologic constituent including hematocrit transcutaneously, noninvasively and continuously. A finger clip assembly includes including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least one predetermined wavelength of light is passed onto or through body tissues such as a finger, earlobe, or scalp, etc. and attenuation of light at that wavelength is detected. Likewise, the change in blood flow is determined by various techniques including optical, pressure, piezo and strain gage methods. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If an additional wavelength of light is used which attenuates light substantially differently by oxyhemoglobin and reduced hemoglobin, then the blood oxygen saturation value, independent of hematocrit may be determined. Further, if an additional wavelength of light is used which greatly attenuates light due to bilirubin (440 nm) or glucose (1060 nm), then the bilirubin or glucose value may also be determined. Also how to determine the hematocrit with a two step DC analysis technique is provided. Then a pulse wave is not required, so this method may be utilized in states of low blood pressure or low blood flow.

Devices, systems and methods are disclosed for the formation of an arteriovenous fistula. Embodiments include catheter apparatus including an ablation element for creating and/or modifying the fistula. The devices, systems and methods can be used to treat patients with one or more numerous ailments including chronic obstructive pulmonary disease, congestive heart failure, hypertension, hypotension, respiratory failure, pulmonary arterial hypertension, lung fibrosis and adult respiratory distress syndrome.

The invention relates to estimation of a patient's propensity to suffer from symptomatic hypotension during extracorporeal blood treatment. An electromagnetic test signal, which is applied over a thoracic region of the patient via at least one transmitter electrode. A result signal produced in response to the test signal is received via at least one receiver electrode on the patient. A test parameter is derived based on the result signal. The test parameter expresses a fluid status of the thoracic region of the patient, and it is determined whether the test parameter fulfills an alarm criterion. If the test parameter fulfills an alarm criteria, an alarm signal is generated. This signal indicates that the patient is hypotension prone, and that appropriate measures should be taken.

A method for treating a patient suffering from one of septic shock, acute kidney injury, severe hypotension, cardiac arrest, and refractory hypotension, but not from myocardial infarction, is provided. The method includes administering a therapeutically effective dose of Angiotensin II, or Ang II, to the patient.

A highly refined cellulose material is a composition of matter is used as an ingredient in the preparation of a neutraceutical in liquid, solid, or tablet form. These compositions may provide an expectation of a health benefit selected from the group consisting of Antioxidation; Cancer prevention; Arterial health improvement; Cholesterol lowering; Reduced blood pressure; Skin and wrinkle treatment; and Prolonging and/or delaying release of a nutrient into a bloodstream.

The invention relates to a piezoelectric sensor for the improved measurement of mechanical variables such as force, pressure or measurement variables which are derived there from, particularly a PVDF film sensor having an improved sensitivity and temperature stability of the measurement signal for pressure measurements that vary in time and/or space, and for the one- and two-dimensional determination of the position and propagation velocity of pressure fluctuations and pressure waves with a single measurement sensor at a measurement location. A preferred field of application of the invention is the non-invasive, low strain and continuous measurement of the pulse rate and the systolic and diastolic blood pressure of humans and animals by determining the velocity and the signal form of the pulse waves. The object of the invention is to allow the measurements of the blood pressure and the pulse rate, for example even in the case of emergency patients having only a very low blood pressure and patients having circulatory disorders in the extremities, for example patients which have developed diabetes or the “smoker's leg”, by using only one sensor at a measurement location due to the improved measurement sensitivity of the piezoelectric sensor, with the result that the continuous application of a pressurized jacket for continuously measuring and monitoring the blood pressure is not necessary. The present invention solves this problem in that a plurality of parallel strips of a piezoelectric material (1) are associated as a measurement membrane in the pressure sensor according to the invention with a sensor base body (4) in such a manner that the parallel strips are tension preloaded in a one-dimensional and elastic manner in the direction of the piezo dipole orientation and that an empty cavity (5) is provided between the tension preloaded piezoelectric sensor material (1) in the measurement portion and the sensor base body (4), formed by a recess/cutout.

The invention relates to a fruit and vegetable yogurt drink and a preparation method thereof. The method comprises the following steps: selecting excellent apples, cucumbers, carrots, radishes, aloes, mango, pineapple, yangtao, sweet potatoes, tomatoes and milk; cleaning and processing the raw materials; preparing fruit and vegetable juice, and homogenizing and degassing the fruit and vegetable juice; mixing the fruit and vegetable juice with the milk; fermenting, homogenizing and sterilizing; cooling and bulking; checking and warehousing. The fruit and vegetable yogurt drink disclosed by the invention achieves micro-molecularization after being juiced, can be absorbed by a human body more easily, has the characteristics of being pleasant in sweetness and sourness, comprehensive and abundant in nutrition, and appetizing, contains a plurality of natural mineral substances such as dietary fibers, protein, vitamin B2, vitamin C, vitamin E, superoxide dismutase (SOD), carotene, nicotinic acid, calcium, phosphorus, ferrum, potassium, copper and selenium, is an excellent yogurt drink, and also has the effects of stimulating a digestive system and an inner circulation system, reducing blood pressure, preventing cancers, clearing away heat and toxic materials, inducing saliva and slaking thirst, tonifying spleen and reinforcing the stomach, eliminating toxin and beautifying skin, and preventing blurring of image.

An apparatus and method of temporarily replacing the function of the left ventricle in a patient whose heart is severely injured and is unable to maintain a systemic arterial pressure adequate to support the inside walls of patient's aorta, the method comprising a removable pressurizable support means having an external profile which is expandable to fit firmly against the inside wall of the aorta of a patient, wherein the external profile of the pressurizable support means presents a central opening that allows blood to flow through the aorta. The pressurizable support means can both support and expand the aorta under low blood pressure to assist the drawing of blood from the left ventricle. The central opening also allows for the placement of a blood flow control means. The blood flow control means can comprise a pumping balloon and a proximal blocking balloon, the two members pressurized and depressurized in opposition within the aorta of a patient to simulate systole and diastole of a healthy heart. The pumping balloon has a pressurized pumping position that is engaged while the proximal blocking balloon is in a depressurized deflated position.

Devices, systems and methods are disclosed for the formation of an arteriovenous fistula in the limb of the patient. Embodiments include an apparatus for the creation, modification and maintenance of a fistula, including the modification of an existing dialysis fistula; and a method of supplying oxygenated blood to the venous circulation of a patient. A kit of anastomotic implants is described which supports a broad base of patient anatomies and fistula locations. The devices, systems and methods can be used to treat patients with one or more numerous ailments including chronic obstructive pulmonary disease, congestive heart failure, hypertension, hypotension, respiratory failure, pulmonary arterial hypertension, lung fibrosis and adult respiratory distress syndrome.

The invention belongs to the technical field of high blood pressure regulating products, and in particular relates to a wearable blood pressure regulating device. The wearable blood pressure regulating device comprises a wearable blood pressure monitoring device and a microneedle type blood pressure dosing device, wherein the microneedle type blood pressure dosing device comprises a wearable wristband, a microneedle medicine device mounted on the wearable wristband, and a spring device mounted on the wearable wristband and used for starting the microneedle medicine device for realizing dosing for the human body, and when the blood pressure value monitored by the wearable blood pressure monitoring device exceeds the set range value, the spring device starts the microneedle medicine device for realizing dosing. The wearable blood pressure regulating device is simple in structure and convenient to use, and can carry out dosing immediately according to the abnormal condition of the blood pressure while monitoring the blood pressure, so that the blood pressure is timely and effectively regulated, thus the blood pressure is maintained to be at a stable numerical value, and finally, the body health of hypertension or hypotension patients is guaranteed.

The invention discloses an anti-cancer and blood pressure-lowering noodle, which is made of the following raw materials by weight part: 70-80 of wheat, 45-55 of rice, 30-40 of millet, 10-12 of cactus lyophilized powder, 10-12 of rape pollen, 20-30 of bovine bone marrow, 8-10 of osmanthus fragrans, 1-2 of Plantain Herb, 2-3 of Phlomis mongolica, 1-2 of radix isatidis, 4-5 of ginkgo leaves, 3-4 of red claw ginger, 20-24 of radix puerariae, 5-6 of grape seed oil, 1-2 of a noodle additive, and a proper amount of water. The noodle provided by the invention adopts wheat, rice, and millet as the main raw materials. The millet has the effects of benefiting spleen and stomach, nourishing kidney qi, promoting dieresis and the like. The bovine bone marrow can moisten lung, tonify kidney, and enrich marrow. The osmanthus fragrans has the effects of dissipating cold and breaking stagnation, reducing phlegm and relieving cough, improving beauty, and relieving throat, etc. The radix puerariae can enhance the regeneration capacity of liver cells, strengthen the liver detoxification function, promote metabolism, clear heat and help produce saliva, lower blood pressure and blood lipid, prevent and resist cancer, beautify skin and improve appearance, etc. The grape seed oil has the effects of resisting oxidation, lightening color spots, regulating internal secretion, delaying aging, and preventing cancer, etc.

Devices and methods are disclosed to address blood pressure control. More particularly, the present invention relates to correction of transient low blood pressure.

The invention relates to a method for predicting blood pressure tendency by multiple blood pressure measurement. The method comprises the following steps: providing a user definite times of blood pressure measurement records selected and accumulated according to suggestion of a doctor or personal willing as a period, then automatically calculating average of blood pressure (containing high blood pressure/low blood pressure) of the period, and making the user easily and quickly acquire the change of self high/low blood pressure through average change of the blood pressure in a previous period and a later period. Therefore, the method is helpful for the user to adjust and improve life habit or provide the average information to the doctors as assistant reference of diagnosis so as to recover a normal blood pressure value.

The present invention puts forward a novel puer tea compound preparation and its preparation technology. It is with puer tea as raw material, through handling the raw materials, deionized water decocting and extracting two times to obtain the extraction, according to compound puer tea extracts65 to 85 percent, taurine 0.03 to 0.05percent, vitamin C 0.04 to 0.06 percent and maltodextrin 15 to 35 percent, mixing, concentrating, drying, granulating and packaging to get finish products. The puer tea granules is unique compound, convenient, good taste, the tests prove that the pure tea has not only hypolipidemic, hypoglycemic, lower blood pressure, but also eliminate free radical and enhance human body immunity effects.

The present invention relates to methods, kits and compositions to treat hypertension and other cardiovascular diseases in a subject, in particular, a method of treating or preventing a cardiovascular disease in a subject comprising administering to a subject at least one anti-miR agent to miRNA-425. In some embodiments, an anti-miR agent is a small molecule or an oligonucleotide complementary to at least part of the miR-425 of SEQ ID NO: 1, or an anti-miR complementary to at least part of the miRNA seed sequence AUGACA (SEQ ID NO: 2). Another aspect of the present invention relates to methods, kits and compositions to treat low blood pressure in a subject comprising administering a composition comprising a miR-425 agent to decrease ANP levels in the subject. Other aspects of the present invention relates to assays, methods and systems to identify a subject at risk of hypertension, or identifying a subject suitable to administration of an anti-miR-425 agent for treatment of hypertension, the assay comprising assessing if a subject is homozygous or heterozygous for the major (A) allele of rs5068 SNP, and/or assaying for levels of miR-425 and/or assaying for levels of NT-proANP and/or levels of ANP in the plasma of a subject.